FDG-PET/CT in the staging of local/regional metastases in breast cancer
Authors:
- Ian J. RobertsonIRIan J. Robertson
- Fiona HandFHFiona Hand
- Malcolm R. KellMKMalcolm R. Kell
Open Access
- 1 December 2011
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 20 (6) , 491-494
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- FDG-PET-CT for staging of high-risk breast cancer patients reduces the number of further examinations: A pilot studyActa Oncologica, 2009
- Preoperative Staging of Large Primary Breast Cancer With [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Compared With Conventional Imaging ProceduresJournal of Clinical Oncology, 2008
- Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancerBMC Cancer, 2008
- A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesAnnals of Oncology, 2006
- American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast CancerJournal of Clinical Oncology, 2005
- The Value of FDG Positron Emission Tomography in the Management of Patients with Breast CancerThe Breast Journal, 2005
- A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assuranceCancer, 2005
- Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?Journal of the American College of Surgeons, 2005
- Prospective Multicenter Study of Axillary Nodal Staging by Positron Emission Tomography in Breast Cancer: A Report of the Staging Breast Cancer With PET Study GroupJournal of Clinical Oncology, 2004
- Prognostic factors in breast cancerSeminars in Surgical Oncology, 1989